We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Genetic Techniques May Lead to New Therapeutic Approaches for Cardiovascular Diseases

By LabMedica International staff writers
Posted on 19 Jun 2014
Print article
A review summarized the state-of-the-art in the field of genome-based therapies for cardiovascular diseases.

Despite statistics showing that the death rate from heart disease has fallen about 39% percent over the past 10 years, heart disease remains the number-one cause of death in the United States, killing almost 380,000 people a year. As several recent approaches to treating the wide range of heart diseases have failed for lack of efficacy, the author of the review, Dr. Daniel J. Rader, professor of genetics at the University of Pennsylvania (Philadelphia, USA) has suggested that human genetics-based technologies have the potential to identify new targets for which the likelihood of therapeutic success is considerably greater.

Among the problems he cited in the June 4, 2014, issue of the journal Science Translational Medicine were (1) many biopharmaceutical companies have begun to back away from efforts to discover and develop therapies for this prevalent disease; (2) seven drugs have failed in phase III clinical trials in the last three to five years; and (3) animal models of atherosclerosis have not proven reliable at predicting new therapies that are effective in humans.

Dr. Rader suggested that as with recent successes in cancer immunotherapy, basing drug targets on human genetics may provide greater confidence that a therapeutic targeted to a particular pathway will show clinical benefit in reducing major cardiovascular events in people. In the review he cited studies of common variants associated with cardiovascular diseases that had yielded nearly 50 statistically significantly associated discrete genetic loci genome-wide. Less than a third were associated with such traditional risk factors as LDL-C (low density lipoprotein-cholesterol) levels or blood pressure, leaving more than 30 loci with no association with traditional measureable risk factors.

"Some of the most interesting new targets for atherosclerotic cardiovascular disease are likely to come from genetic studies of common and rare variants, comparing individuals with early disease with those who are free of disease," said Dr. Rader.

Related Links:
University of Pennsylvania


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Automated Blood Typing System
IH-500 NEXT
New
Liquid Based Cytology Production Machine
LBP-4032
New
Free Human Prostate-Specific Antigen CLIA
LIAISON fPSA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.